Global Gene Knockdown Market Growth (Status and Outlook) 2025-2031

January 2025 | 138 pages | ID: GB79B11DA8C9EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Gene Knockdown market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Gene Knockdown is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Gene Knockdown is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Gene Knockdown is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Gene Knockdown players cover Santa Cruz Biotechnology (US), OriGene (US), Sigma-Aldrich (US), Abnova (Taiwan), Agilent Technologies (US), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Gene Knockdown Industry Forecast” looks at past sales and reviews total world Gene Knockdown sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Knockdown sales for 2025 through 2031. With Gene Knockdown sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Knockdown industry.

This Insight Report provides a comprehensive analysis of the global Gene Knockdown landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Knockdown portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Knockdown market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Knockdown and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Knockdown.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Knockdown market by product type, application, key players and key regions and countries.

Segmentation by Type:

• siRNA
• shRNA
• Other

Segmentation by Application:

• Medical
• Bioengineering
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Santa Cruz Biotechnology (US)
• OriGene (US)
• Sigma-Aldrich (US)
• Abnova (Taiwan)
• Agilent Technologies (US)
• Bio-Rad (US)
• Cell Signaling Technology (US)
• GeneCopoeia (US)
• siTOOLs Biotech (Germany)
• Novus Biologicals (US)
• EMD Millipore (US)
• BioVision (US)
• Creative Biomart (US)
• Selleck Chemicals (US)
• MyBioSource (US)
• Invitrogen (US)
• Qiagen (Germany)

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Gene Knockdown Market Size (2020-2031)
  2.1.2 Gene Knockdown Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Gene Knockdown by Country/Region (2020, 2024 & 2031)
2.2 Gene Knockdown Segment by Type
  2.2.1 siRNA
  2.2.2 shRNA
  2.2.3 Other
2.3 Gene Knockdown Market Size by Type
  2.3.1 Gene Knockdown Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Gene Knockdown Market Size Market Share by Type (2020-2025)
2.4 Gene Knockdown Segment by Application
  2.4.1 Medical
  2.4.2 Bioengineering
  2.4.3 Other
2.5 Gene Knockdown Market Size by Application
  2.5.1 Gene Knockdown Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Gene Knockdown Market Size Market Share by Application (2020-2025)

3 GENE KNOCKDOWN MARKET SIZE BY PLAYER

3.1 Gene Knockdown Market Size Market Share by Player
  3.1.1 Global Gene Knockdown Revenue by Player (2020-2025)
  3.1.2 Global Gene Knockdown Revenue Market Share by Player (2020-2025)
3.2 Global Gene Knockdown Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 GENE KNOCKDOWN BY REGION

4.1 Gene Knockdown Market Size by Region (2020-2025)
4.2 Global Gene Knockdown Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gene Knockdown Market Size Growth (2020-2025)
4.4 APAC Gene Knockdown Market Size Growth (2020-2025)
4.5 Europe Gene Knockdown Market Size Growth (2020-2025)
4.6 Middle East & Africa Gene Knockdown Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Gene Knockdown Market Size by Country (2020-2025)
5.2 Americas Gene Knockdown Market Size by Type (2020-2025)
5.3 Americas Gene Knockdown Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Gene Knockdown Market Size by Region (2020-2025)
6.2 APAC Gene Knockdown Market Size by Type (2020-2025)
6.3 APAC Gene Knockdown Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Gene Knockdown Market Size by Country (2020-2025)
7.2 Europe Gene Knockdown Market Size by Type (2020-2025)
7.3 Europe Gene Knockdown Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Gene Knockdown by Region (2020-2025)
8.2 Middle East & Africa Gene Knockdown Market Size by Type (2020-2025)
8.3 Middle East & Africa Gene Knockdown Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL GENE KNOCKDOWN MARKET FORECAST

10.1 Global Gene Knockdown Forecast by Region (2026-2031)
  10.1.1 Global Gene Knockdown Forecast by Region (2026-2031)
  10.1.2 Americas Gene Knockdown Forecast
  10.1.3 APAC Gene Knockdown Forecast
  10.1.4 Europe Gene Knockdown Forecast
  10.1.5 Middle East & Africa Gene Knockdown Forecast
10.2 Americas Gene Knockdown Forecast by Country (2026-2031)
  10.2.1 United States Market Gene Knockdown Forecast
  10.2.2 Canada Market Gene Knockdown Forecast
  10.2.3 Mexico Market Gene Knockdown Forecast
  10.2.4 Brazil Market Gene Knockdown Forecast
10.3 APAC Gene Knockdown Forecast by Region (2026-2031)
  10.3.1 China Gene Knockdown Market Forecast
  10.3.2 Japan Market Gene Knockdown Forecast
  10.3.3 Korea Market Gene Knockdown Forecast
  10.3.4 Southeast Asia Market Gene Knockdown Forecast
  10.3.5 India Market Gene Knockdown Forecast
  10.3.6 Australia Market Gene Knockdown Forecast
10.4 Europe Gene Knockdown Forecast by Country (2026-2031)
  10.4.1 Germany Market Gene Knockdown Forecast
  10.4.2 France Market Gene Knockdown Forecast
  10.4.3 UK Market Gene Knockdown Forecast
  10.4.4 Italy Market Gene Knockdown Forecast
  10.4.5 Russia Market Gene Knockdown Forecast
10.5 Middle East & Africa Gene Knockdown Forecast by Region (2026-2031)
  10.5.1 Egypt Market Gene Knockdown Forecast
  10.5.2 South Africa Market Gene Knockdown Forecast
  10.5.3 Israel Market Gene Knockdown Forecast
  10.5.4 Turkey Market Gene Knockdown Forecast
10.6 Global Gene Knockdown Forecast by Type (2026-2031)
10.7 Global Gene Knockdown Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Gene Knockdown Forecast

11 KEY PLAYERS ANALYSIS

11.1 Santa Cruz Biotechnology (US)
  11.1.1 Santa Cruz Biotechnology (US) Company Information
  11.1.2 Santa Cruz Biotechnology (US) Gene Knockdown Product Offered
  11.1.3 Santa Cruz Biotechnology (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Santa Cruz Biotechnology (US) Main Business Overview
  11.1.5 Santa Cruz Biotechnology (US) Latest Developments
11.2 OriGene (US)
  11.2.1 OriGene (US) Company Information
  11.2.2 OriGene (US) Gene Knockdown Product Offered
  11.2.3 OriGene (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 OriGene (US) Main Business Overview
  11.2.5 OriGene (US) Latest Developments
11.3 Sigma-Aldrich (US)
  11.3.1 Sigma-Aldrich (US) Company Information
  11.3.2 Sigma-Aldrich (US) Gene Knockdown Product Offered
  11.3.3 Sigma-Aldrich (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Sigma-Aldrich (US) Main Business Overview
  11.3.5 Sigma-Aldrich (US) Latest Developments
11.4 Abnova (Taiwan)
  11.4.1 Abnova (Taiwan) Company Information
  11.4.2 Abnova (Taiwan) Gene Knockdown Product Offered
  11.4.3 Abnova (Taiwan) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Abnova (Taiwan) Main Business Overview
  11.4.5 Abnova (Taiwan) Latest Developments
11.5 Agilent Technologies (US)
  11.5.1 Agilent Technologies (US) Company Information
  11.5.2 Agilent Technologies (US) Gene Knockdown Product Offered
  11.5.3 Agilent Technologies (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Agilent Technologies (US) Main Business Overview
  11.5.5 Agilent Technologies (US) Latest Developments
11.6 Bio-Rad (US)
  11.6.1 Bio-Rad (US) Company Information
  11.6.2 Bio-Rad (US) Gene Knockdown Product Offered
  11.6.3 Bio-Rad (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Bio-Rad (US) Main Business Overview
  11.6.5 Bio-Rad (US) Latest Developments
11.7 Cell Signaling Technology (US)
  11.7.1 Cell Signaling Technology (US) Company Information
  11.7.2 Cell Signaling Technology (US) Gene Knockdown Product Offered
  11.7.3 Cell Signaling Technology (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Cell Signaling Technology (US) Main Business Overview
  11.7.5 Cell Signaling Technology (US) Latest Developments
11.8 GeneCopoeia (US)
  11.8.1 GeneCopoeia (US) Company Information
  11.8.2 GeneCopoeia (US) Gene Knockdown Product Offered
  11.8.3 GeneCopoeia (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 GeneCopoeia (US) Main Business Overview
  11.8.5 GeneCopoeia (US) Latest Developments
11.9 siTOOLs Biotech (Germany)
  11.9.1 siTOOLs Biotech (Germany) Company Information
  11.9.2 siTOOLs Biotech (Germany) Gene Knockdown Product Offered
  11.9.3 siTOOLs Biotech (Germany) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 siTOOLs Biotech (Germany) Main Business Overview
  11.9.5 siTOOLs Biotech (Germany) Latest Developments
11.10 Novus Biologicals (US)
  11.10.1 Novus Biologicals (US) Company Information
  11.10.2 Novus Biologicals (US) Gene Knockdown Product Offered
  11.10.3 Novus Biologicals (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Novus Biologicals (US) Main Business Overview
  11.10.5 Novus Biologicals (US) Latest Developments
11.11 EMD Millipore (US)
  11.11.1 EMD Millipore (US) Company Information
  11.11.2 EMD Millipore (US) Gene Knockdown Product Offered
  11.11.3 EMD Millipore (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 EMD Millipore (US) Main Business Overview
  11.11.5 EMD Millipore (US) Latest Developments
11.12 BioVision (US)
  11.12.1 BioVision (US) Company Information
  11.12.2 BioVision (US) Gene Knockdown Product Offered
  11.12.3 BioVision (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 BioVision (US) Main Business Overview
  11.12.5 BioVision (US) Latest Developments
11.13 Creative Biomart (US)
  11.13.1 Creative Biomart (US) Company Information
  11.13.2 Creative Biomart (US) Gene Knockdown Product Offered
  11.13.3 Creative Biomart (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Creative Biomart (US) Main Business Overview
  11.13.5 Creative Biomart (US) Latest Developments
11.14 Selleck Chemicals (US)
  11.14.1 Selleck Chemicals (US) Company Information
  11.14.2 Selleck Chemicals (US) Gene Knockdown Product Offered
  11.14.3 Selleck Chemicals (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Selleck Chemicals (US) Main Business Overview
  11.14.5 Selleck Chemicals (US) Latest Developments
11.15 MyBioSource (US)
  11.15.1 MyBioSource (US) Company Information
  11.15.2 MyBioSource (US) Gene Knockdown Product Offered
  11.15.3 MyBioSource (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 MyBioSource (US) Main Business Overview
  11.15.5 MyBioSource (US) Latest Developments
11.16 Invitrogen (US)
  11.16.1 Invitrogen (US) Company Information
  11.16.2 Invitrogen (US) Gene Knockdown Product Offered
  11.16.3 Invitrogen (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 Invitrogen (US) Main Business Overview
  11.16.5 Invitrogen (US) Latest Developments
11.17 Qiagen (Germany)
  11.17.1 Qiagen (Germany) Company Information
  11.17.2 Qiagen (Germany) Gene Knockdown Product Offered
  11.17.3 Qiagen (Germany) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
  11.17.4 Qiagen (Germany) Main Business Overview
  11.17.5 Qiagen (Germany) Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Gene Knockdown Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gene Knockdown Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of siRNA
Table 4. Major Players of shRNA
Table 5. Major Players of Other
Table 6. Gene Knockdown Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Gene Knockdown Market Size byType (2020-2025) & ($ millions)
Table 8. Global Gene Knockdown Market Size Market Share byType (2020-2025)
Table 9. Gene Knockdown Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Gene Knockdown Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Gene Knockdown Market Size Market Share by Application (2020-2025)
Table 12. Global Gene Knockdown Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Gene Knockdown Revenue Market Share by Player (2020-2025)
Table 14. Gene Knockdown Key Players Head office and Products Offered
Table 15. Gene Knockdown Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Gene Knockdown Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Gene Knockdown Market Size Market Share by Region (2020-2025)
Table 20. Global Gene Knockdown Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Gene Knockdown Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Gene Knockdown Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Gene Knockdown Market Size Market Share by Country (2020-2025)
Table 24. Americas Gene Knockdown Market Size byType (2020-2025) & ($ millions)
Table 25. Americas Gene Knockdown Market Size Market Share byType (2020-2025)
Table 26. Americas Gene Knockdown Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Gene Knockdown Market Size Market Share by Application (2020-2025)
Table 28. APAC Gene Knockdown Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Gene Knockdown Market Size Market Share by Region (2020-2025)
Table 30. APAC Gene Knockdown Market Size byType (2020-2025) & ($ millions)
Table 31. APAC Gene Knockdown Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Gene Knockdown Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Gene Knockdown Market Size Market Share by Country (2020-2025)
Table 34. Europe Gene Knockdown Market Size byType (2020-2025) & ($ millions)
Table 35. Europe Gene Knockdown Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Gene Knockdown Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Gene Knockdown Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa Gene Knockdown Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Gene Knockdown
Table 40. Key Market Challenges & Risks of Gene Knockdown
Table 41. Key IndustryTrends of Gene Knockdown
Table 42. Global Gene Knockdown Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global Gene Knockdown Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global Gene Knockdown Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global Gene Knockdown Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. Santa Cruz Biotechnology (US) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 47. Santa Cruz Biotechnology (US) Gene Knockdown Product Offered
Table 48. Santa Cruz Biotechnology (US) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Santa Cruz Biotechnology (US) Main Business
Table 50. Santa Cruz Biotechnology (US) Latest Developments
Table 51. OriGene (US) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 52. OriGene (US) Gene Knockdown Product Offered
Table 53. OriGene (US) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. OriGene (US) Main Business
Table 55. OriGene (US) Latest Developments
Table 56. Sigma-Aldrich (US) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 57. Sigma-Aldrich (US) Gene Knockdown Product Offered
Table 58. Sigma-Aldrich (US) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Sigma-Aldrich (US) Main Business
Table 60. Sigma-Aldrich (US) Latest Developments
Table 61. Abnova (Taiwan) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 62. Abnova (Taiwan) Gene Knockdown Product Offered
Table 63. Abnova (Taiwan) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Abnova (Taiwan) Main Business
Table 65. Abnova (Taiwan) Latest Developments
Table 66. AgilentTechnologies (US) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 67. AgilentTechnologies (US) Gene Knockdown Product Offered
Table 68. AgilentTechnologies (US) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. AgilentTechnologies (US) Main Business
Table 70. AgilentTechnologies (US) Latest Developments
Table 71. Bio-Rad (US) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 72. Bio-Rad (US) Gene Knockdown Product Offered
Table 73. Bio-Rad (US) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Bio-Rad (US) Main Business
Table 75. Bio-Rad (US) Latest Developments
Table 76. Cell SignalingTechnology (US) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 77. Cell SignalingTechnology (US) Gene Knockdown Product Offered
Table 78. Cell SignalingTechnology (US) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Cell SignalingTechnology (US) Main Business
Table 80. Cell SignalingTechnology (US) Latest Developments
Table 81. GeneCopoeia (US) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 82. GeneCopoeia (US) Gene Knockdown Product Offered
Table 83. GeneCopoeia (US) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. GeneCopoeia (US) Main Business
Table 85. GeneCopoeia (US) Latest Developments
Table 86. siTOOLs Biotech (Germany) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 87. siTOOLs Biotech (Germany) Gene Knockdown Product Offered
Table 88. siTOOLs Biotech (Germany) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. siTOOLs Biotech (Germany) Main Business
Table 90. siTOOLs Biotech (Germany) Latest Developments
Table 91. Novus Biologicals (US) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 92. Novus Biologicals (US) Gene Knockdown Product Offered
Table 93. Novus Biologicals (US) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Novus Biologicals (US) Main Business
Table 95. Novus Biologicals (US) Latest Developments
Table 96. EMD Millipore (US) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 97. EMD Millipore (US) Gene Knockdown Product Offered
Table 98. EMD Millipore (US) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. EMD Millipore (US) Main Business
Table 100. EMD Millipore (US) Latest Developments
Table 101. BioVision (US) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 102. BioVision (US) Gene Knockdown Product Offered
Table 103. BioVision (US) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. BioVision (US) Main Business
Table 105. BioVision (US) Latest Developments
Table 106. Creative Biomart (US) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 107. Creative Biomart (US) Gene Knockdown Product Offered
Table 108. Creative Biomart (US) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Creative Biomart (US) Main Business
Table 110. Creative Biomart (US) Latest Developments
Table 111. Selleck Chemicals (US) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 112. Selleck Chemicals (US) Gene Knockdown Product Offered
Table 113. Selleck Chemicals (US) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Selleck Chemicals (US) Main Business
Table 115. Selleck Chemicals (US) Latest Developments
Table 116. MyBioSource (US) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 117. MyBioSource (US) Gene Knockdown Product Offered
Table 118. MyBioSource (US) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. MyBioSource (US) Main Business
Table 120. MyBioSource (US) Latest Developments
Table 121. Invitrogen (US) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 122. Invitrogen (US) Gene Knockdown Product Offered
Table 123. Invitrogen (US) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Invitrogen (US) Main Business
Table 125. Invitrogen (US) Latest Developments
Table 126. Qiagen (Germany) Details, CompanyType, Gene Knockdown Area Served and Its Competitors
Table 127. Qiagen (Germany) Gene Knockdown Product Offered
Table 128. Qiagen (Germany) Gene Knockdown Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Qiagen (Germany) Main Business
Table 130. Qiagen (Germany) Latest Developments



LIST OFFIGURES

Figure 1. Gene Knockdown Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Knockdown Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gene Knockdown Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gene Knockdown Sales Market Share by Country/Region (2024)
Figure 8. Gene Knockdown Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gene Knockdown Market Size Market Share byType in 2024
Figure 10. Gene Knockdown in Medical
Figure 11. Global Gene Knockdown Market: Medical (2020-2025) & ($ millions)
Figure 12. Gene Knockdown in Bioengineering
Figure 13. Global Gene Knockdown Market: Bioengineering (2020-2025) & ($ millions)
Figure 14. Gene Knockdown in Other
Figure 15. Global Gene Knockdown Market: Other (2020-2025) & ($ millions)
Figure 16. Global Gene Knockdown Market Size Market Share by Application in 2024
Figure 17. Global Gene Knockdown Revenue Market Share by Player in 2024
Figure 18. Global Gene Knockdown Market Size Market Share by Region (2020-2025)
Figure 19. Americas Gene Knockdown Market Size 2020-2025 ($ millions)
Figure 20. APAC Gene Knockdown Market Size 2020-2025 ($ millions)
Figure 21. Europe Gene Knockdown Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Gene Knockdown Market Size 2020-2025 ($ millions)
Figure 23. Americas Gene Knockdown Value Market Share by Country in 2024
Figure 24. United States Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Gene Knockdown Market Size Market Share by Region in 2024
Figure 29. APAC Gene Knockdown Market Size Market Share byType (2020-2025)
Figure 30. APAC Gene Knockdown Market Size Market Share by Application (2020-2025)
Figure 31. China Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 35. India Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Gene Knockdown Market Size Market Share by Country in 2024
Figure 38. Europe Gene Knockdown Market Size Market Share byType (2020-2025)
Figure 39. Europe Gene Knockdown Market Size Market Share by Application (2020-2025)
Figure 40. Germany Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 41.France Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Gene Knockdown Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Gene Knockdown Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Gene Knockdown Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Gene Knockdown Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 54. APAC Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 55. Europe Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 57. United States Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 58. Canada Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 59. Mexico Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 60. Brazil Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 61. China Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 62. Japan Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 63. Korea Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 65. India Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 66. Australia Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 67. Germany Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 68.France Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 69. UK Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 70. Italy Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 71. Russia Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 72. Egypt Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 73. South Africa Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 74. Israel Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 75.Turkey Gene Knockdown Market Size 2026-2031 ($ millions)
Figure 76. Global Gene Knockdown Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Gene Knockdown Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Gene Knockdown Market Size 2026-2031 ($ millions)